Frontage Holdings Corporation

HK$1.49As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1521Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (10.10%)
Div yield —
ROE 3.05%
Biotechnology
Beta (5Y) 0.19
PE TTM 36.53
TSR TTM 25.21%
Mkt cap HK$3.031B
ROIC 3.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.75
17.76%
218.92%
Hold 4|7|11|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
23.76%
17.17%
10.90%
10.60%
Revenue$M
143.4
144.1
146.2
146.6
7.96%
7.63%
11.65%
6.50%
Peers (US$386.6M)
Cap (US$)
PE
353.6M
16.80x
328.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.466
0.026
0.021
EBIT/Intx
0.440
0.362
0.351
Own earn%
34.61
(15.02)
(17.17)
Sh yield%
38.94
42.62
45.51
Owners
Insiders/Inst%
9.63
32.23
Short interest%
5.06
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
26–33
$1 testx
−0.1
Incr. ROIC%
7